Additional symptoms include foot pain, an increased risk for corns and calluses, and a higher risk for foot ulcers, especially for individuals with diabetes
GLP-1 medications can produce substantial caloric restriction through appetite suppression and early satiety, leading to weight loss that may exceed 15-20% of body weight over several months with higher doses of semaglutide 2.4 mg or tirzepatide
Many patients find that 1224 months on medication provides enough time to build new eating habits that persist even if they eventually discontinuethough continued treatment remains the best strategy to prevent regain
Approval was granted by the Ethics Committee of Erzincan Binali Yldrm University (Date 26.04.2021/ Permit Number: E-21142744-804-.99-77978, Decision No: 06/29)
The result is what dental professionals now call "Ozempic teeth," a pattern of accelerated decay, increased sensitivity, and gum disease appearing in patients on GLP-1 medications
